1. Weiss, S. W. and Goldblum, J. R. (2001) Enzinger and Weiss’s Soft Tissue Tumors, 4th ed. Mosby, Philadelphia, pp. 1–19.
2. Kempson, R. L., Fletcher, C. D. M., Evans, H. E., Hendrickson, M. R., and Sibley, R. K. (2001) Tumors of the soft tissues, in Atlas of Tumor Pathology, 3rd series. Fascicle
30. ( Rosai, J. and Sobin, L. H., eds.), Armed Forces Institute of Pathology, Washington, D.C., pp. 1–21.
3. Brennan, M. F., Alektiar, K. M., and Maki, R. G. (2001) Sarcomas of the soft tissue and bone, in Cancer: Principles and Practice of Oncology. ( DeVita, V. T. J., Hellman, S., and Rosenberg, S. A., eds.), Lippincott, Williams & Wilkins, Philadelphia, pp. 1841–1891.
4. Buchdunger, E., Cioffi, C. L., Law, N., et al. (2000) Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J. Pharmacol. Exp. Ther.
295, 139–145.
5. van Oosterom, A. T., Judson, I., Verweij, J., et al. (2001) Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet
358, 1421–1423.